Mednet Logo
HomeRadiation OncologyQuestion

Do you recommend holding a TKI when treating brain metastases with SRS/WBRT?

8
1 Answers
Mednet Member
Mednet Member
Radiation Oncology · University of Toronto Faculty of Medicine

There are a few publications which help address this very pertinent question. The phase 3 trial of whole brain radiation therapy (WBRT) and stereotactic radiosurgery (SRS) alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: RTOG 0320 (...

Register or Sign In to see full answer